MedTrace Logo

Efficacy and Safety of DTMS in Adolescent Major Depressive Disorder

NCT06728280 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-03-12

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to explore the efficacy and safety of two different dTMS devices in adolescent depression: deep TMS H1 coil and deep TMS H7 coil.

The main questions it aims to answer are:

Type of study: Clinical trial. Participant population: Adolescents with major depressive disorder (MDD). Objective: To explore whether the H7 coil is no less effective than the H1 coil for adolescents with MDD, further providing clinicians with additional treatment options for patients.

Conditions

  • Major Depressive Diorder

Interventions

DEVICE

deep transcranial magnetic stimulation with H1coil

Participants will receive dTMS treatment with H1 coil

DEVICE

deep transcranial magnetic stimulation with H7 coil

Participants will receive dTMS treatment with H7 coil

Sponsors & Collaborators

  • Zhifen Liu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06728280 on ClinicalTrials.gov